CLASP-IID trial: For patients with suboptimal mitral #TEER results, those with MR ≤1+ & mean gradient >5 mmHg had better 1-yr prognosis than MR ≥2+ & gradient ≤5 mmHg. Favors optimizing MR over preserving lower gradient. https://t.co/yEVRvqhjzk
#JACCIMG#vhdMR@AkhilNarangMD